中新网上海3月18日电（记者 陈静 陈青人 肖鑫）记者今日获悉，上海细胞治疗研究院院长钱其军教授成功通过国际知名医学期刊《柳叶刀》的严格资格审查，获聘为该期刊的编辑顾问。这一任命不仅是对钱教授个人学术成就的肯定，也将进一步提升中国在细胞治疗领域的基础科研实力。
钱其军教授是国内外细胞治疗领域的领军人物，他在肿瘤免疫治疗和干细胞治疗方面取得了多项重要研究成果。此次受聘为《柳叶刀》的编辑顾问，不仅体现了国际同行对钱教授学术水平和专业能力的认可，也标志着中国在生命科学领域的研究影响力正在逐步增强。
《柳叶刀》是全球最负盛名的医学期刊之一，其编辑顾问团队由81位来自世界各地的资深医学专家组成。钱教授的加入，是中国学者在该期刊编辑团队中的又一重要代表。他的工作将有助于提高《柳叶刀》在相关领域的审稿质量和研究方向的前沿性，同时也有助于促进国际细胞治疗研究的交流与合作。
此外，钱教授还将利用这一平台，推广中国在该领域的研究成果，提升中国医学研究的国际地位。随着中国在生命科学领域的不断进步，可以预见，将有越来越多的中国学者在国际学术舞台上发挥重要作用。
英文标题：Shanghai Cell Therapy Institute Director Professor Qijun Qian Appointed as Editorial Adviser for The Lancet
英文关键词：Cell Therapy, Editorial Advisory, Scientific Research Capability
英文新闻内容：
SHANGHAI, March 18 (Xinhua) — Professor Qijun Qian, director of the Shanghai Institute of Cell Therapy, has been appointed as an editorial adviser for The Lancet, a prestigious international medical journal, according to a press release on Friday.
The appointment is a recognition of Professor Qian’s academic achievements and contributions to the field of cell therapy, which includes cancer immunotherapy and stem cell therapy. It also reflects the growing influence of China’s research in the life sciences.
Professor Qian’s expertise and insights will enhance the quality of peer review and the relevance of research directions at The Lancet, while also facilitating the exchange and cooperation of international cell therapy research.
Moreover, Professor Qian will use this platform to promote China’s research results in this field and raise the international status of Chinese medical research. With China’s continuous progress in the life sciences, it is expected that more Chinese scholars will play a significant role on the international academic stage.
【来源】http://www.chinanews.com/life/2024/03-18/10182251.shtml
Views: 1